[
  {
    "title": "Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials",
    "year": 1998,
    "study_type": "Systematic review and meta-analysis of randomized trials",
    "population": "Men with erectile dysfunction",
    "results_summary": "This systematic review and meta-analysis of randomized trials evaluated yohimbine in men with erectile dysfunction. Results showed that superiority to placebo with infrequent serious adverse reactions in short-term trials; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials.” PubMed, 1998, https://pubmed.ncbi.nlm.nih.gov/9649257/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/9649257/"
  },
  {
    "title": "Double‑blind, placebo‑controlled safety and efficacy trial with yohimbine hydrochloride in nonorganic erectile dysfunction",
    "year": 1997,
    "study_type": "Randomized double-blind placebo-controlled trial",
    "population": "Men with nonorganic erectile dysfunction",
    "results_summary": "This randomized double-blind placebo-controlled trial evaluated yohimbine hydrochloride in men with nonorganic erectile dysfunction. Results showed that higher response rate than placebo with generally mild adverse events; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Double‑blind, placebo‑controlled safety and efficacy trial with yohimbine hydrochloride in nonorganic erectile dysfunction.” PubMed, 1997, https://pubmed.ncbi.nlm.nih.gov/9315493/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/9315493/"
  },
  {
    "title": "Double-blind trial of yohimbine in treatment of psychogenic impotence",
    "year": 1987,
    "study_type": "Randomized double-blind controlled trial",
    "population": "Men with psychogenic impotence",
    "results_summary": "This randomized double-blind controlled trial evaluated yohimbine in men with psychogenic impotence. Results showed that improved clinical global impression compared with placebo in nonorganic cases; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Double-blind trial of yohimbine in treatment of psychogenic impotence.” PubMed, 1987, https://pubmed.ncbi.nlm.nih.gov/2887726/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/2887726/"
  },
  {
    "title": "Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction",
    "year": 1996,
    "study_type": "Randomized double-blind placebo-controlled study",
    "population": "Men with erectile dysfunction",
    "results_summary": "This randomized double-blind placebo-controlled study evaluated yohimbine in men with erectile dysfunction. Results showed that subjective improvement in nonorganic cases without significant NPTR changes; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction.” PubMed, 1996, https://pubmed.ncbi.nlm.nih.gov/8714425/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/8714425/"
  },
  {
    "title": "Efficacy and Safety of Oral Combination of Yohimbine and L‑Arginine (SX) in Treatment of Mild to Moderate Erectile Dysfunction",
    "year": 2010,
    "study_type": "Randomized double-blind placebo-controlled trial",
    "population": "Married men aged 25–50 with mild to moderate erectile dysfunction",
    "results_summary": "This randomized double-blind placebo-controlled trial evaluated combination of yohimbine and L‑arginine in men with mild to moderate erectile dysfunction. Results showed that improved IIEF erectile function domain versus placebo with similar tolerability; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Efficacy and Safety of Oral Combination of Yohimbine and L‑Arginine (SX) in Treatment of Mild to Moderate Erectile Dysfunction.” PubMed, 2010, https://pubmed.ncbi.nlm.nih.gov/22952481/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/22952481/"
  },
  {
    "title": "Yohimbine as a treatment for erectile dysfunction: a systematic review and meta-analysis",
    "year": 2021,
    "study_type": "Systematic review and meta-analysis",
    "population": "Men with erectile dysfunction across randomized trials",
    "results_summary": "This systematic review and meta-analysis evaluated yohimbine alone or in combination in men with erectile dysfunction. Results showed that improved erectile function versus placebo with heterogeneity and older trials noted; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Yohimbine as a treatment for erectile dysfunction: a systematic review and meta-analysis.” PubMed, 2021, https://pubmed.ncbi.nlm.nih.gov/35118966/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/35118966/"
  },
  {
    "title": "Yohimbine in erectile dysfunction: the facts",
    "year": 2000,
    "study_type": "Narrative review",
    "population": "Men with erectile dysfunction",
    "results_summary": "This narrative review evaluated yohimbine in men with erectile dysfunction. Results showed that summary of clinical evidence suggesting modest benefit and need for modern RCTs; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Yohimbine in erectile dysfunction: the facts.” PubMed, 2000, https://pubmed.ncbi.nlm.nih.gov/10849568/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/10849568/"
  },
  {
    "title": "Yohimbine in therapy of erectile dysfunction",
    "year": 1998,
    "study_type": "Review",
    "population": "Men with erectile dysfunction",
    "results_summary": "This review evaluated yohimbine in men with erectile dysfunction. Results showed that concluded superiority to placebo with fewer side effects than invasive treatments based on then-available RCTs; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Yohimbine in therapy of erectile dysfunction.” PubMed, 1998, https://pubmed.ncbi.nlm.nih.gov/9522535/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/9522535/"
  },
  {
    "title": "Pharmacology and safety considerations for yohimbine in humans",
    "year": 2001,
    "study_type": "Narrative safety review",
    "population": "Adults exposed to yohimbine",
    "results_summary": "This narrative safety review evaluated yohimbine in adults exposed to yohimbine. Results showed that potential for hypertension, tachycardia, anxiety, and drug interactions; caution advised; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Pharmacology and safety considerations for yohimbine in humans.” PubMed, 2001, https://pubmed.ncbi.nlm.nih.gov/11550783/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/11550783/"
  },
  {
    "title": "Adrenergic mechanisms and penile erection: effects of yohimbine",
    "year": 1984,
    "study_type": "Clinical pharmacology study",
    "population": "Men undergoing laboratory erectile testing",
    "results_summary": "This clinical pharmacology study evaluated yohimbine in men undergoing laboratory erectile testing. Results showed that physiologic enhancements consistent with alpha‑2 antagonism; mostly minor adverse events reported. Effects were generally modest and safety signals were acceptable, but larger and longer trials are recommended.",
    "mla_citation": "“Adrenergic mechanisms and penile erection: effects of yohimbine.” PubMed, 1984, https://pubmed.ncbi.nlm.nih.gov/6147098/. Accessed 24 Oct. 2025.",
    "url": "https://pubmed.ncbi.nlm.nih.gov/6147098/"
  }
]